Spacing Lidcombe Program Clinic Visits
The Effect of Spacing of Lidcombe Program Clinic Visits
2 other identifiers
interventional
120
2 countries
2
Brief Summary
The purpose of this study is to evaluate the efficiency of the Lidcombe Program for early stuttering by varying the time between clinic visits during the first stage of the program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jan 2008
Typical duration for phase_2
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 15, 2008
CompletedFirst Posted
Study publicly available on registry
May 20, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedMay 20, 2008
April 1, 2008
1.9 years
May 15, 2008
May 15, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
1. Number of clinic visits required to achieve Stage II (0-1%SS, Severity Rating=1) 2. Number of clinic days to achieve Stage II 3. Percent Syllables Stuttered (%SS) at entry to Stage II
Entry into Stage II
Secondary Outcomes (1)
Parent reported Severity Ratings (SR)
Pre-treatment, entry into Stage 2, 9 months post-randomization, 18 months post-randomization
Study Arms (3)
1
EXPERIMENTALThe child will receive the Lidcombe Program 2x per week
2
EXPERIMENTALThe child will receive the Lidcombe Program once every 2 weeks (fortnightly visits)
3
OTHERThe child will receive the standard Lidcombe Program once per week (control)
Interventions
Eligibility Criteria
You may qualify if:
- ;0-5;11 years of age
- Stuttering for longer than 6 months
- Functional English spoken by parent and child
- Stuttering over 2%SS in one Beyond Clinic measure
- Diagnosis of stuttering
You may not qualify if:
- Less than 2%SS
- Previous treatment for stuttering in last 6 months
- Parental report of ADHD or intellectual disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Sydneylead
- National Health and Medical Research Council, Australiacollaborator
- Newcastle Universitycollaborator
Study Sites (2)
University of Newcastle
Newcastle, New South Wales, 2308, Australia
The Montreal Fluency Centre
Montreal, Quebec, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Onslow
University of Sydney
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 15, 2008
First Posted
May 20, 2008
Study Start
January 1, 2008
Primary Completion
December 1, 2009
Study Completion
December 1, 2010
Last Updated
May 20, 2008
Record last verified: 2008-04